Mirum Pharmaceuticals, Inc. (MIRM) Tops Q1 EPS by 5c

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) reported Q1 EPS of ($0.80), $0.05 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $31.6 million versus the consensus estimate of $26.07 million.

For earnings history and earnings-related data on Mirum Pharmaceuticals, Inc. (MIRM) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• AMC Entertainment prices $200M stock offering to redeem senior notes